| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.64B | 14.98B | 11.29B | 12.02B | 8.34B | 10.86B |
| Gross Profit | 12.13B | 14.01B | 10.99B | 11.79B | 8.14B | 10.77B |
| EBITDA | 3.37B | 4.99B | 912.00M | 1.29B | -1.69B | 568.00M |
| Net Income | 2.84B | 3.94B | 2.65B | 1.30B | -2.96B | 875.00M |
Balance Sheet | ||||||
| Total Assets | 71.93B | 71.95B | 69.39B | 80.75B | 66.19B | 80.37B |
| Cash, Cash Equivalents and Short-Term Investments | 23.61B | 22.30B | 22.46B | 25.63B | 24.17B | 29.33B |
| Total Debt | 13.74B | 12.76B | 11.36B | 10.01B | 10.25B | 15.76B |
| Total Liabilities | 45.33B | 41.31B | 39.26B | 41.35B | 31.99B | 41.94B |
| Stockholders Equity | 26.60B | 30.64B | 30.12B | 39.40B | 34.20B | 38.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.18B | 518.00M | 2.95B | -2.89B | -6.73B |
| Operating Cash Flow | 0.00 | -3.77B | 853.00M | 3.49B | -2.58B | -4.07B |
| Investing Cash Flow | 0.00 | 2.18B | 2.29B | 1.51B | 78.00M | 70.00M |
| Financing Cash Flow | 0.00 | -2.11B | -5.46B | -2.10B | -4.65B | -495.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥85.73B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
75 Outperform | ¥69.64B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
70 Outperform | ¥200.00B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | ¥44.71B | 16.68 | ― | 4.36% | 3.23% | -11.76% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥233.66B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
57 Neutral | ¥46.11B | 9.21 | ― | 4.86% | 10.70% | 63.03% |